{"gao_id": "GAO-23-105650", "published": "2023-03-10T12:00:00Z", "released": "2023-03-10T07:00:00Z", "summary": "The Food and Drug Administration has promoted advanced manufacturing\u2014i.e., innovative technologies\u2014as a way to address drug shortages. For example, it approved 2 drugs made using advanced manufacturing to treat a COVID-19 complication. But we found that few drugs are manufactured using this technology, and the FDA doesn't know if all of its efforts to increase the technology's use are working. The agency hasn't formalized performance...", "title": "Drug Manufacturing: FDA Should Fully Assess Its Efforts to Encourage Innovation", "topics": ["Manufacturing", "Science and technology", "Generic drugs", "Supply chain management", "Health Care", "Drugs", "pandemics", "Performance measurement", "Prescription drugs", "New technologies", "Pharmaceutical industry"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-23-105650", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-23-105650-highlights.pdf"}, {"title": "Full Report (43 pages)", "url": "https://www.gao.gov/assets/gao-23-105650.pdf"}, {"title": "Accessible PDF (49 pages)", "url": "https://www.gao.gov/assets/820/818048.pdf"}]}